Skip to search formSkip to main contentSkip to account menu

T 138067

Known as: T-138067, T138067 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Growing evidence indicates that the antiapoptotic protein survivin is a major factor of drug and radiation resistance in cancer… 
2007
2007
5164 Previous studies demonstrated that the aberrant expression of survivin, a protein with a central role in the inhibition of… 
2004
2004
4087 Background: T67 is a novel irreversible tubulin inhibitor currently being studied in a pivotal trial for the treatment of… 
2003
2003
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2003
2003
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2001
2001
The novel anticancer compound T138067 is an irreversible inhibitor of tubulin polymerization. Amides 3-6 were synthesized using… 
2000
2000
Nature provides a large spectrum of agents that either inhibit the polymerization of tubulin or prevent the disassembly of…